Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1038)
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
17,353
Price
$102.10
Total Value
$1.77M
Shares Held After
326,990
% of Holdings
5.0%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
7,429
Price
$101.48
Total Value
$753.89K
Shares Held After
344,343
% of Holdings
2.1%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
1,408
Price
$99.77
Total Value
$140.48K
Shares Held After
351,772
% of Holdings
0.4%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
1,699
Price
$98.54
Total Value
$167.42K
Shares Held After
353,180
% of Holdings
0.5%
Verastem, Inc. (VSTM)
Paterson Dan — Director
Shares
806
Price
$5.82
Total Value
$4.69K
Shares Held After
612,113
% of Holdings
0.1%
Axsome Therapeutics, Inc. (AXSM)
Jacobson Mark L. — Chief Operating Officer
Shares
4,517
Price
$227.94
Total Value
$1.03M
Shares Held After
0
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
72,884
Price
$6.80
Total Value
$495.61K
Shares Held After
198,890
% of Holdings
26.8%
ACADIA PHARMACEUTICALS INC (ACAD)
Kihara James — PRINCIPAL ACCOUNTING OFFICER
Shares
1,332
Price
$21.79
Total Value
$29.02K
Shares Held After
29,129
% of Holdings
4.4%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
3,506
Price
$21.79
Total Value
$76.40K
Shares Held After
66,145
% of Holdings
5.0%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bhatia Sangeeta N. — Director
Shares
318
Price
$423.73
Total Value
$134.75K
Shares Held After
4,924
% of Holdings
6.1%
Surrozen, Inc./DE (SRZN)
Parker Craig C — Director
Shares
4,524
Price
$33.33
Total Value
$150.80K
Shares Held After
16,553
% of Holdings
21.5%
Surrozen, Inc./DE (SRZN)
Williams Charles O — Chief Operating Officer
Shares
2,036
Price
$33.33
Total Value
$67.87K
Shares Held After
16,571
% of Holdings
10.9%
Surrozen, Inc./DE (SRZN)
Li Yang — Exec. Vice President, Research
Shares
1,584
Price
$33.33
Total Value
$52.80K
Shares Held After
17,216
% of Holdings
8.4%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
172
Price
$157.49
Total Value
$27.09K
Shares Held After
2,666
% of Holdings
6.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
235
Price
$156.57
Total Value
$36.79K
Shares Held After
2,838
% of Holdings
7.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
325
Price
$155.21
Total Value
$50.44K
Shares Held After
3,073
% of Holdings
9.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
236
Price
$154.24
Total Value
$36.40K
Shares Held After
3,398
% of Holdings
6.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
32
Price
$153.50
Total Value
$4.91K
Shares Held After
3,634
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
400
Price
$582.29
Total Value
$232.92K
Shares Held After
18,876
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
520
Price
$581.28
Total Value
$302.27K
Shares Held After
19,276
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
440
Price
$580.26
Total Value
$255.31K
Shares Held After
19,796
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,160
Price
$579.13
Total Value
$671.79K
Shares Held After
20,236
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
719
Price
$577.54
Total Value
$415.25K
Shares Held After
21,396
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
3,005
Price
$576.66
Total Value
$1.73M
Shares Held After
22,115
% of Holdings
12.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,436
Price
$575.75
Total Value
$1.40M
Shares Held After
25,120
% of Holdings
8.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
487
Price
$574.84
Total Value
$279.95K
Shares Held After
27,556
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
153
Price
$573.82
Total Value
$87.79K
Shares Held After
28,043
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
480
Price
$572.40
Total Value
$274.75K
Shares Held After
28,196
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$571.00
Total Value
$22.84K
Shares Held After
28,676
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$570.06
Total Value
$45.60K
Shares Held After
28,716
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$568.60
Total Value
$45.49K
Shares Held After
28,796
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$582.29
Total Value
$139.75K
Shares Held After
40,513
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
401
Price
$581.78
Total Value
$233.29K
Shares Held After
40,753
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$580.98
Total Value
$325.35K
Shares Held After
41,154
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,104
Price
$579.27
Total Value
$639.52K
Shares Held After
41,714
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$578.58
Total Value
$92.57K
Shares Held After
42,818
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,039
Price
$577.26
Total Value
$599.77K
Shares Held After
42,978
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,677
Price
$576.39
Total Value
$2.12M
Shares Held After
44,017
% of Holdings
7.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,320
Price
$575.45
Total Value
$759.60K
Shares Held After
47,694
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
359
Price
$574.37
Total Value
$206.20K
Shares Held After
49,014
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$572.42
Total Value
$251.86K
Shares Held After
49,373
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$570.99
Total Value
$22.84K
Shares Held After
49,813
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$569.64
Total Value
$68.36K
Shares Held After
49,853
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$568.36
Total Value
$22.73K
Shares Held After
49,973
% of Holdings
0.1%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
5,230
Price
$31.29
Total Value
$163.66K
Shares Held After
4,367
% of Holdings
54.5%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$33.20
Total Value
$67.53K
Shares Held After
231,558
% of Holdings
0.9%
Entrada Therapeutics, Inc. (TRDA)
Dowden Nathan J — President & COO
Shares
15,000
Price
$15.33
Total Value
$229.95K
Shares Held After
198,588
% of Holdings
7.0%
Entrada Therapeutics, Inc. (TRDA)
Sethuraman Natarajan — President, Research & Develop.
Shares
25,907
Price
$15.39
Total Value
$398.81K
Shares Held After
216,317
% of Holdings
10.7%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
8,148
Price
$16.96
Total Value
$138.21K
Shares Held After
18,305
% of Holdings
30.8%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
47,963
Price
$0.72
Total Value
$34.53K
Shares Held After
1,679,330
% of Holdings
2.8%
Showing 801–850 of 1038 transactions (page 17 of 21)